---
title: "Kalohexis confidentially files IPO to back obesity and cachexia portfolio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292066714.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-08T10:40:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292066714.md)
  - [en](https://longbridge.com/en/news/292066714.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292066714.md)
---

# Kalohexis confidentially files IPO to back obesity and cachexia portfolio

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

## Related News & Research

- [Adult epilepsy market to reach $17.bn across 7MM by 2035](https://longbridge.com/en/news/293805836.md)
- [Cellares and Papillon partner for PPL-001 manufacturing automation](https://longbridge.com/en/news/293446287.md)
- [Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval](https://longbridge.com/en/news/293465734.md)
- [AAIC26: Alzheimer’s disease heterogeneity calls for a rethink](https://longbridge.com/en/news/293348271.md)
- [What Ojemda’s JCA reveals about new era of clinical HTA in Europe](https://longbridge.com/en/news/293247752.md)